New pill joins fight against tough bile duct cancers
NCT ID NCT02151084
Summary
This study is testing if adding a new pill called selumetinib to standard chemotherapy helps people with advanced bile duct or gallbladder cancer more than chemotherapy alone. It will compare two different schedules of the drug combination. The main goal is to see if the new combinations shrink tumors better or keep the cancer from growing for longer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BILIARY TRACT CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Princess Margaret Cancer Centre
Toronto, Ontario, M5G 2M9, Canada
Conditions
Explore the condition pages connected to this study.